HRH Princess Astrid of Belgium visits Telix’s New European Manufacturing Facility in Brussels South

Melbourne (Australia) & Liège (Belgium) | 27 September 2023

Telix has welcomed Her Royal Highness, Princess Astrid, Princess of Belgium to Telix Manufacturing Solutions (TMS), the Company’s recently inaugurated production facility, in Brussels South (Seneffe) in the Wallonia region of Belgium.

Located in the heart of Belgium’s ‘Radiopharma Valley’, the 2,800 square metre facility is one of Europe’s largest radiopharmaceutical production facilities. With more than 10 million imaging procedures performed in the EU using radiopharmaceutical agents every year,[1] Telix’s site provides important infrastructure to meet the growing demand for commercial and clinical imaging and therapeutic agents, for patients in the Europe Middle East and Africa (EMEA) region and beyond.

The royal visit comes ahead of the Belgian Economic Mission to Australia, which will take place in Melbourne and Sydney from 19 to 28 October 2023. The mission – led by HRH, Princess Astrid of Belgium, Representative of His Majesty the King of Belgium – features events that highlight successful collaboration between Belgium and Australia. Telix is co-hosting a seminar with The Peter MacCallum Cancer Centre in Melbourne on the subject of innovation in nuclear medicine.

Raphael Ortiz, Telix EMEA CEO said “Telix was honoured to welcome HRH Princess Astrid, the Ambassador Dirk Wouters, Laurent Michel and the Bourgmestre Bénédicte Poll at Telix Manufacturing Solutions, which recently opened in Brussels South. Belgium’s ‘Radiopharma Valley’ is a fundamental part of Telix’s innovation success with this latest example of Telix’s continued investment in innovation to serve as a hub for research, development and manufacturing for our partners and collaborators across industry, academia and clinical practice. We would like to thank the Princess for her interest in nuclear medicine and radiopharmaceuticals, and look forward to showcasing the Australian side of the business during next month’s trade mission.”

Pascale Delcomminette, Wallonia Export & Investment Agency (Awex) CEO, added, “TMS is a prime example of the innovative solutions made possible by a strong business partnership between Belgium and Australia. With the trade mission less than a month away, we are pleased that HRH Princess Astrid could see first-hand this facility that has potential to transform care for patients with cancer and rare diseases in Belgium, Europe and worldwide.”

To read the full media release click here


[1] European Commission, Joint Research Centre, Mario, N., Kolmayer, A., Turquet, G.et al., Study on sustainable and resilient supply of medical radioisotopes in the EU https://data.europa.eu/doi/10.2760/911131